You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
譽衡藥業(002437.SZ):前三季預增106.24%-115.91%
格隆匯 10-14 18:59

格隆匯10月14日丨譽衡藥業(002437.SZ)發佈2020年前三季度業績預告,歸屬於上市公司股東的淨利潤6.4億元-6.7億元,同比增長106.24%-115.91%;基本每股收益0.29-0.30元。

預計第三季度歸屬於上市公司股東的淨虧損0萬元-3000.00萬元,去年同期則為淨利潤7803.34萬元;基本每股虧損0-0.01元/股.

報告期內,公司業績較上年同期有所增長主要源於非經常性損益的影響,其中主要為公司在報告期內確認出售澳諾(中國)製藥有限公司100%股權獲得的相關收益所致,預計本次出售的非經常性損益對淨利潤的影響金額約為6.87億元。

剔除上述因素,受新冠肺炎疫情及醫藥行業政策等影響,公司前三季度經營業績較去年同期出現較大幅度的下降,報告期內,公司扣除非經常性損益後的淨虧損約為8000萬元至5000萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account